Abstract
Five major types of viral hepatitis have been described. The recent detection of the delta, C, and E agents has made possible the description of the clinical spectra of the disease. The recent recommendation on the universal immunization against hepatitis B has been a major step towards prevention of HBV infection. Recent studies have shown that interferon alfa-2a and alfa-2b may be useful in those with chronic hepatitis B and C. Future investigations are needed so that treatment and prevention of the other viral entities, especially in those who are immunocompromised, may be instituted. Liver transplantation offers hope in a subset of patients with end-stage liver disease.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
